Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients—A Prospective Study

Immune response to two SARS-CoV-2 mRNA vaccine doses among kidney transplant recipients (KTRs) is limited. We aimed to evaluate humoral and cellular response to a third BNT162b2 dose. In this prospective study, 190 KTRs were evaluated before and ∼3 weeks after the third vaccine dose. The primary out...

Descripción completa

Detalles Bibliográficos
Autores principales: Yahav, Dafna, Rahamimov, Ruth, Mashraki, Tiki, Ben-Dor, Naomi, Steinmetz, Tali, Agur, Timna, Zingerman, Boris, Herman-Edelstein, Michal, Lichtenberg, Shelly, Ben-Zvi, Haim, Bar-Haim, Erez, Cohen, Hila, Rotem, Shahar, Elia, Uri, Margalit, Ili, Zvi, Benaya Rozen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068869/
https://www.ncbi.nlm.nih.gov/pubmed/35529596
http://dx.doi.org/10.3389/ti.2022.10204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068869/
https://www.ncbi.nlm.nih.gov/pubmed/35529596
http://dx.doi.org/10.3389/ti.2022.10204

Ejemplares similares